Stephen A Sherwin - Net Worth and Insider Trading
Stephen A Sherwin Net Worth
The estimated net worth of Stephen A Sherwin is at least $6 Million dollars as of 2024-04-20. Stephen A Sherwin is the Director of Neurocrine Biosciences Inc and owns about 25,055 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $3 Million. Stephen A Sherwin is the Director of Biogen Inc and owns about 15,438 shares of Biogen Inc (BIIB) stock worth over $3 Million. Stephen A Sherwin is also the Director of Fresh Tracks Therapeutics Inc and owns about 2 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $2. Details can be seen in Stephen A Sherwin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen A Sherwin has not made any transactions after 2023-01-03 and currently still holds the listed stock(s).
Transaction Summary of Stephen A Sherwin
Stephen A Sherwin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen A Sherwin owns 12 companies in total, including Biogen Inc (BIIB) , Neurocrine Biosciences Inc (NBIX) , and Neon Therapeutics Inc (NTGN) among others .
Click here to see the complete history of Stephen A Sherwin’s form 4 insider trades.
Insider Ownership Summary of Stephen A Sherwin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BIIB | Biogen Inc | 2020-03-11 | director |
NBIX | Neurocrine Biosciences Inc | 2023-01-03 | director |
NTGN | Neon Therapeutics Inc | 2020-05-06 | director |
ADRO | Aduro Biotech Inc | 2020-05-05 | director |
RIGL | Rigel Pharmaceuticals Inc | 2003-07-28 | director |
VSTM | Verastem Inc | 2013-03-05 | director |
FRTX | Fresh Tracks Therapeutics Inc | 2013-05-23 | director |
ANIP | ANI Pharmaceuticals Inc | 2009-10-14 | director |
KDNY | Chinook Therapeutics Inc | 2018-06-06 | director |
BIOS | BioPlus Acquisition Corp | 2021-12-02 | director |
EPHY | Epiphany Technology Acquisition Corp | 2022-09-16 | director |
EPHYU | Epiphany Technology Acquisition Corp | 2022-09-16 | director |
Stephen A Sherwin Latest Holdings Summary
Stephen A Sherwin currently owns a total of 3 stocks. Among these stocks, Stephen A Sherwin owns 25,055 shares of Neurocrine Biosciences Inc (NBIX) as of January 3, 2023, with a value of $3 Million and a weighting of 52.41%. Stephen A Sherwin owns 15,438 shares of Biogen Inc (BIIB) as of March 11, 2020, with a value of $3 Million and a weighting of 47.59%. Stephen A Sherwin also owns 2 shares of Fresh Tracks Therapeutics Inc (FRTX) as of May 23, 2013, with a value of $2 and a weighting of 0%.
Latest Holdings of Stephen A Sherwin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NBIX | Neurocrine Biosciences Inc | 2023-01-03 | 25,055 | 131.96 | 3,306,258 |
BIIB | Biogen Inc | 2020-03-11 | 15,438 | 194.44 | 3,001,688 |
FRTX | Fresh Tracks Therapeutics Inc | 2013-05-23 | 2 | 0.90 | 2 |
Holding Weightings of Stephen A Sherwin
Stephen A Sherwin Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen A Sherwin has made a total of 3 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 30,000 shares on January 3, 2023, which brought Stephen A Sherwin around $4 Million.
According to the SEC Form 4 filings, Stephen A Sherwin has made a total of 1 transactions in Biogen Inc (BIIB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Biogen Inc is the sale of 2,434 shares on March 11, 2020, which brought Stephen A Sherwin around $718,566.
According to the SEC Form 4 filings, Stephen A Sherwin has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 2 shares on May 23, 2013, which cost Stephen A Sherwin around $70.
Insider Trading History of Stephen A Sherwin
- 1
Stephen A Sherwin Trading Performance
GuruFocus tracks the stock performance after each of Stephen A Sherwin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen A Sherwin is -62.29%. GuruFocus also compares Stephen A Sherwin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen A Sherwin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen A Sherwin's insider trading performs compared to the benchmark.
Performance of Stephen A Sherwin
Average Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -16.76 | -62.29 | -69.27 | -65.64 | -49.19 | -52.21 |
Relative Return to S&P 500(%) | -13.24 | -63.08 | -78.62 | -80.79 | -62.71 | -59.66 |
Stephen A Sherwin Ownership Network
Ownership Network List of Stephen A Sherwin
Ownership Network Relation of Stephen A Sherwin
Stephen A Sherwin Owned Company Details
What does Biogen Inc do?
Who are the key executives at Biogen Inc?
Stephen A Sherwin is the director of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , Head of Research Jane Grogan , and EVP & Human Resources Ginger Gregory .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Stephen A Sherwin made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 2,797 shares made by Priya Singhal , a net sale of 8,291 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .
In summary, during the past 3 months, insiders sold 1,516 shares of Biogen Inc (BIIB) in total and bought 455 shares, with a net sale of 1,061 shares. During the past 18 months, 16,620 shares of Biogen Inc (BIIB) were sold and 455 shares were bought by its insiders, resulting in a net sale of 16,165 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Stephen A Sherwin Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen A Sherwin. You might contact Stephen A Sherwin via mailing address: C/o Cell Genesys, Inc., 500 Forbes Blvd., South San Francisco Ca 94080.